Pharma is next in line as Trump says tariffs are coming ‘very shortly’news2025-04-09T10:36:07+00:00April 9th, 2025|Endpoints News|
Pharma CEOs warn EU of potential US exodus as trade war continuesnews2025-04-08T19:23:18+00:00April 8th, 2025|Endpoints News|
Drug tool and packaging makers to feel brunt of Trump tariffs, analysts saynews2025-04-07T17:05:24+00:00April 7th, 2025|Endpoints News|
Cell and gene therapy CDMO AmplifyBio shuts down over ‘scarcity’ of fundingnews2025-04-07T10:26:49+00:00April 7th, 2025|Endpoints News|
China’s retaliatory tariffs on US could mean more headwinds for drugmakersnews2025-04-04T17:25:01+00:00April 4th, 2025|Endpoints News|
SHL Medical opens $220M autoinjector site; DHL acquires clinical trial firm news2025-04-03T15:58:57+00:00April 3rd, 2025|Endpoints News|
Trump’s tariff rollout leaves many questions for drugmakersnews2025-04-03T00:08:58+00:00April 3rd, 2025|Endpoints News|
Trump’s tariffs could leave the pharma industry scramblingnews2025-04-02T20:48:38+00:00April 2nd, 2025|Endpoints News|
New CDMO emerges, acquires cell and gene manufacturer Landmark Bionews2025-04-02T09:00:38+00:00April 2nd, 2025|Endpoints News|
Milestone’s shares dive after FDA again rejects drug for abnormal heart rhythmnews2025-03-28T14:51:44+00:00March 28th, 2025|Endpoints News|
